Aviance Capital Partners’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73M Sell
120,657
-9,002
-7% -$109K 0.2% 99
2025
Q4
$1.28M Sell
129,659
-1,254
-1% -$12.1K 0.15% 127
2025
Q3
$1.29M Sell
130,913
-4,965
-4% -$42.4K 0.15% 131
2025
Q2
$1.18M Buy
135,878
+2,819
+2% +$26.7K 0.15% 136
2025
Q1
$1.24M Buy
133,059
+31,776
+31% +$327K 0.17% 127
2024
Q4
$1.02M Buy
101,283
+12,875
+15% +$161K 0.14% 143
2024
Q3
$1.15M Buy
88,408
+13,830
+19% +$200K 0.15% 149
2024
Q2
$1.07M Buy
74,578
+16,838
+29% +$276K 0.15% 135
2024
Q1
$1M Buy
57,740
+2,164
+4% +$31.2K 0.15% 145
2023
Q4
$754K Sell
55,576
-609
-1% -$8.38K 0.16% 141
2023
Q3
$725K Sell
56,185
-1,193
-2% -$14.9K 0.16% 145
2023
Q2
$748K Buy
57,378
+23,734
+71% +$289K 0.16% 152
2023
Q1
$414K Buy
33,644
+945
+3% +$10.1K 0.09% 184
2022
Q4
$284K Buy
32,699
+12,712
+64% +$134K 0.07% 231
2022
Q3
$207K Buy
19,987
+970
+5% +$12.8K 0.05% 243
2022
Q2
$250K Buy
19,017
+192
+1% +$2.78K 0.06% 235
2022
Q1
$285K Buy
+18,825
New +$316K 0.05% 222

Other funds holding SWBI

Aviance Capital Partners's SWBI Position: Q1 2026 in Review

Aviance Capital Partners reduced its Smith & Wesson (SWBI) stake by 6.9% in Q1 2026, selling an estimated $109K and leaving 120,657 shares worth $1.73M. The position accounts for 0.2% of the portfolio, ranked #99.

Aviance Capital Partners first reported a position in SWBI in Q1 2022 and has held it in 17 quarters since. 190 funds tracked by Wall St. Rank hold SWBI as of Q1 2026.

  • Aviance Capital Partners held 120,657 shares of Smith & Wesson worth $1.73M as of Q1 2026.
  • Aviance Capital Partners sold 9,002 Smith & Wesson shares in Q1 2026, an estimated $109K.
  • Smith & Wesson made up 0.2% of Aviance Capital Partners's portfolio in Q1 2026, its #99 holding.
  • Aviance Capital Partners first reported a position in Smith & Wesson in Q1 2022 and has held it in 17 quarters since.
  • 190 funds tracked by Wall St. Rank held Smith & Wesson as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.